about
Identification of granulocyte colony-stimulating factor and interleukin-6 as candidate biomarkers of CBLB502 efficacy as a medical radiation countermeasureγ-Tocotrienol as a Promising Countermeasure for Acute Radiation Syndrome: Current StatusRadioprotective efficacy of delta-tocotrienol, a vitamin E isoform, is mediated through granulocyte colony-stimulating factorMedical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patentsMedical countermeasures for unwanted CBRN exposures: Part I chemical and biological threats with review of recent countermeasure patents.Carnein, a serine protease from noxious plant weed Ipomoea carnea (morning glory).Tocopherol succinate: a promising radiation countermeasure.Radioprotective Efficacy of Gamma-Tocotrienol in Nonhuman Primates.Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates.Radioprotection of hematopoietic progenitors by low dose amifostine prophylaxis.Progenitors mobilized by gamma-tocotrienol as an effective radiation countermeasure.Purification, crystallization and preliminary X-ray crystallographic analysis of MIL, a glycosylated jacalin-related lectin from mulberry (Morus indica) latex.Medical Countermeasures for Radiation Exposure and Related Injuries: Characterization of Medicines, FDA-Approval Status and Inclusion into the Strategic National Stockpile.Immunomodulation by lead.Tocols induce G-CSF and mobilise progenitors that mitigate radiation injuryRadiation countermeasure agents: an update (2011-2014)Role of cytokines and growth factors in radioprotection.Patents for Toll-like receptor ligands as radiation countermeasures for acute radiation syndromeCombined immunomodulator and antimicrobial therapy eliminates polymicrobial sepsis and modulates cytokine production in combined injured miceUse of biomarkers for assessing radiation injury and efficacy of countermeasuresProgenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure.Alpha-tocopherol succinate- and AMD3100-mobilized progenitors mitigate radiation combined injury in mice.A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute.Colony-stimulating factors for the treatment of the hematopoietic component of the acute radiation syndrome (H-ARS): a review.Animal models for acute radiation syndrome drug discovery.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part II. Countermeasures for limited indications, internalized radionuclides, emesis, late effects, and agents demonstrating efficacy in larNonhuman primates as models for the discovery and development of radiation countermeasures.A review of radiation countermeasures focusing on injury-specific medicinals and regulatory approval status: part I. Radiation sub-syndromes, animal models and FDA-approved countermeasures.Recombinant surfactant protein-D selectively increases apoptosis in eosinophils of allergic asthmatics and enhances uptake of apoptotic eosinophils by macrophages.N-palmitoylation of the radioprotective domain of interleukin-1 affords inhibition of LPS-induced nitric oxide generation.Inhibition of LPS-induced nitric oxide production in RAW cells by radioprotective thiols.Anticellular and immunosuppressive properties of ethanolic extract of Acorus calamus rhizome.Immunomodulation by ethanolic extract of Boerhaavia diffusa roots.Inhibition of antigen specific lymphocyte proliferation and cytokine stimulation by peptidomimetic opioid compound.Antilymphoproliferative activity of ethanolic extract of Boerhaavia diffusa roots.Lipidomic Signatures of Nonhuman Primates with Radiation-Induced Hematopoietic Syndrome.A novel analytical brain block tool to enable functional annotation of discriminatory transcript biomarkers among discrete regions of the fronto-limbic circuit in primate brain.Tumor necrosis factor-α-mediated severity of idiopathic retinal periphlebitis in young adults (Eales' disease): implication for anti-TNF-α therapy.Preclinical development of a bridging therapy for radiation casualties: appropriate for high risk personnel.Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol.
P50
Q24627006-4FF1E4DB-5952-4A65-A7F7-CF523041A02EQ26751505-6E598001-F87C-4FD5-81A7-3E466062E4FFQ28307079-65CF6CD4-C0CF-4438-B737-70A8322DB602Q28817576-76D8AAEB-0B87-446F-A51B-F8673F262382Q30245600-FD771381-5187-44F9-8DA3-5170092D723AQ33287879-03E5B7AC-F73C-4CE1-9076-5DBF73572DC0Q33386137-A17C189A-C71C-4D6A-BFA4-1C8EBC0B76C2Q33430401-8B58AA02-4EF9-495E-A1B8-7D41E681C89CQ33718841-C84E7CC6-6BC1-4FC9-B7E7-D52E78D85688Q34049808-46834A85-7AB4-4C32-BD0C-C5EBFC3BD6D6Q34572191-A911A0C7-444B-4874-A45E-A49EB9F79020Q34925669-0D1D574E-249E-48E4-9589-DE384826CC13Q35566671-7026EED3-A364-4BFB-802A-055C98A0932FQ35580893-EBF1EC25-EB9F-400A-901F-6AC5081FE5B4Q35616543-88067760-3218-4C9A-B228-819FE9382D95Q35626587-34A93EB7-4B76-49DE-A9C3-0A8AFD1FF819Q36043127-A4EDCD27-D28E-4BBC-A75C-18B4FBD029B4Q36357104-543BADBB-C0D4-4D0E-8D14-279DA1B7BA28Q36357204-99101736-FED1-4C9B-B24B-44E48EC15B0FQ36519142-C79F4EA2-AD4F-42B8-A15D-26E5275F2D54Q37074231-F33D6849-46F2-4296-970F-70130FDF52FAQ37450638-3179F20A-A7AE-4184-9E09-7A92543C2CC8Q37970729-45CC4961-B6E4-4878-BFE1-DB973F161787Q38248625-79BC60BC-ACA3-411A-BD7B-F736BB4D6716Q38394740-66F6589D-151B-469D-BCF7-D2FC365540BEQ38665691-59C03DD4-0DC7-438F-AE49-911ABF5722B6Q39261890-C78653B6-B00C-42CC-B620-D48D5184C022Q39398444-24000908-6B4F-498A-B739-41C1C7919A37Q39961206-4F42899F-E14B-4D62-9E12-9051D25E41B0Q40543055-56CEFCC9-FE60-433E-B441-6F4C708884B7Q40662904-170726A0-450B-4C15-AE6A-96ED19C8F700Q40676124-DEF7DF2B-C16C-4691-BED9-F42C69792CF0Q40709665-0FCAA672-7066-4F37-A12B-06AAF5B36456Q40721164-529E894A-CE26-4371-9D56-8F84FA563721Q40732269-10CD00FB-FC32-4112-A9BC-9ED903DCAE0CQ41548303-2A24CF97-20B6-45F2-8840-6F6DEA6FA895Q41662327-410C5426-80E3-4C04-9162-4BE593E42BBDQ41819850-2403391E-F71E-4D17-8167-8DEA72CD00E4Q41962624-426FCB6A-096C-46EE-B5A5-5642FB842426Q42167281-90F4998B-DD2E-4A79-B17B-7435F2497212
P50
description
researcher ORCID ID = 0000-0002-6631-3849
@en
name
Vijay K Singh
@ast
Vijay K Singh
@en
Vijay K Singh
@es
Vijay K Singh
@nl
type
label
Vijay K Singh
@ast
Vijay K Singh
@en
Vijay K Singh
@es
Vijay K Singh
@nl
prefLabel
Vijay K Singh
@ast
Vijay K Singh
@en
Vijay K Singh
@es
Vijay K Singh
@nl
P108
P1153
36065868700
P31
P496
0000-0002-6631-3849